COVID-19: Vaccines
Last updated 5th December 2020, 1935 UK timeMedicines and Healthcare products Regulatory Agency - Coronavirus - VaccinesNHS - Coronavirus vaccinesEuropean Medicines Agency - COVID-19 vaccinesDepartment of Health and Social Care announcement of the approval of the Pfizer/BioNTech vaccinePublic Health England ' sPublic Health Matters blogpost about the role of the MHRA and Joint Committee for Vaccination and Immunisations. Find the latest research with this PubMed search (Source: Browsing)
Source: Browsing - December 5, 2020 Category: Databases & Libraries Tags: coronavirus COVID-19 NCOV Source Type: blogs
TWiV 689: COVID-19 clinical update #39 with Dr. Daniel Griffin
Daniel Griffin provides his weekly clinical report on COVID-19, including analysis of vitamin D levels in patients, information on Moderna and Pfizer vaccines, distribution plans suggested by ACIP, and more. Click arrow to playDownload TWiV 689 (22 MB .mp3, 37 min)Subscribe (free): iTunes, Google Podcasts, RSS, email Become a patron of TWiV! Show notes at microbe.tv/twiv (Source: virology blog)
Source: virology blog - December 5, 2020 Category: Virology Authors: Vincent Racaniello Tags: This Week in Virology coronavirus COVID-19 pandemic SARS-CoV-2 vaccine viral viruses vitamin D Source Type: blogs
The Miracle of Modern Medical Research
Marian L. TupyHumanity has suffered from deadly diseases for millennia without fully knowing what they were, how they were transmitted, or how they could be cured. Smallpox, which killed between 300 million and 500 million people in the 20th century alone, originated in either India or Egypt at least 3,000 years ago. But it was not until the late 18th century that the English physician Edward Jenner vaccinated his first patient against the disease. It took another two centuries before smallpox was finally eradicated in 1980. Similar stories can be told about other killer diseases. The fate of humanity, our ancestors t...
Source: Cato-at-liberty - December 4, 2020 Category: American Health Authors: Marian L. Tupy Source Type: blogs
It Is Important To Remember That No Amount Of Technology Can Prevent Human Error.
This appeared last week: Software glitch changing doses on GP scripts for RHD drug The issue could result in potential under-dosing in patients with acute rheumatic fever and rheumatic heart disease 25th November 2020 By Kemal Atlay A glitch in Best Practice software means the wrong dosages have been printed when doctors issue repeat scripts for a rheumatic heart disease (RHD) treatment. SA Health has urged all GPs who manage patients with acute rheumatic fever or RHD to be aware of the issue when prescribing Bicillin LA injections, warning it could result in significant under-dosing. The issue emerged after Pfizer changed...
Source: Australian Health Information Technology - December 4, 2020 Category: Information Technology Authors: Dr David G More MB PhD Source Type: blogs
Why There ’ s Hope In 2021
ALMOST THEREWe’re finally about to leave this dreadful 2020 behind! This year was stacked with natural and man-made disasters, economic and mental collapse, bleeding healthcare and the untimely and unnecessary deaths of hundreds of thousands. No wonder we are all waiting for the year to end and find some peace of mind that it will all be over soon – and that 2021 will be better.
And hope, indeed, is what we have. Because throughout 2020, amazing advances have given hope that rose in science, technology, digital health, leadership and in basic human care and kindness. Anti-racist books topping the lists. More people ...
Source: The Medical Futurist - December 3, 2020 Category: Information Technology Authors: Judit Kuszkó Tags: Forecast Digital Health Research E-Patients Future of Medicine Future of Pharma Healthcare Design Healthcare Policy science fake news politics 2020 leadership jumanji lockdown vaccine hope 2021 pfizer BioNTech Source Type: blogs
“Drug Lag” and the COVID Vaccine
Jeffrey A. SingerThe U.K ’s Medicines and Healthcare products Regulatory Agency (MHRA)announced this morning that it has approved the Pfizer/ BioNTech COVID vaccine and expects to begin immunizing its population within a week. This vaccine, along with one independently developed by Moderna Pharmaceuticals, are the first evermRNA vaccines, which use a newprocess that can potentially be used against other infectious diseases and even to treat or preventcancer. Clinical trials show both of these vaccines to be95 percent effective. They also have an excellentsafety profile thus far —in part because they don’...
Source: Cato-at-liberty - December 2, 2020 Category: American Health Authors: Jeffrey A. Singer Source Type: blogs
What, Us Worry
By KIM BELLARD
2020 has been an awful year. Hurricanes, wildfires, murder hornets, unjustified shootings, a divisive Presidential election, and, of course, a pandemic. Most of us are spending unprecedented amounts of time sheltering in place, millions have lost their jobs, the economy is sputtering, and over a quarter million of us didn’t survive to Thanksgiving. If you haven’t been depressed at some point, you haven’t been paying enough attention.
Within the last two weeks, though, there has finally been some cause for hope. Whether you want to credit Operation Warp Speed or just sc...
Source: The Health Care Blog - November 25, 2020 Category: Consumer Health News Authors: Christina Liu Tags: COVID-19 Health Policy COVID-19 vaccine Kim Bellard Source Type: blogs
Can the Government Mandate a Covid-19 Vaccine? Will It Have To?
Conclusion
As governments assess how to contend with reaching effective levels of vaccination, they are preparing to tread carefully around vaccine skepticism while transparently and apolitically addressing common concerns about safety and due process. Attitudes could change as vaccines are distributed to the public and, hopefully, demonstrate safety and effectiveness, encouraging individuals to rapidly vaccinate.
For government, a heavy-handed approach could backfire, fueling further anti-government/anti-science sentiment, but not pursuing vaccination with ample vigor could mean a prolonged timeline for co...
Source: The Health Care Blog - November 23, 2020 Category: Consumer Health News Authors: Christina Liu Tags: COVID-19 Health Policy COVID-19 vaccine Phillip Meylan Source Type: blogs
Will anyone take the COVID-19 vaccine when it ’s approved?
Finally, 2020 has offered some encouraging news, with Pfizer and Moderna publishing recent results that provide initial evidence of their vaccine ’s ability to prevent COVID-19. With the recent promising results from both vaccine trials, it seems like only a matter of time before the FDA approves them. While some hurdles remain before the vaccine’s distribution […]Find jobs at Careers by KevinMD.com. Search thousands of physician, PA, NP, and CRNA jobs now. Learn more. (Source: Kevin, M.D. - Medical Weblog)
Source: Kevin, M.D. - Medical Weblog - November 21, 2020 Category: General Medicine Authors: < span itemprop="author" > < a href="https://www.kevinmd.com/blog/post-author/garrett-rossi" rel="tag" > Garrett Rossi, MD < /a > < /span > Tags: Conditions COVID-19 coronavirus Infectious Disease Source Type: blogs
TWiV 683: Two COVID-19 mRNA vaccines
On this episode of TWiV, mRNA vaccines from Moderna and Pfizer show over 90% efficacy, prothrombotic auto-antibodies in serum of COVID-19 patients, and the whereabouts of SARS-CoV-2 in the human body. Click arrow to playDownload TWiV 683 (72 MB .mp3, 119 min)Subscribe (free): iTunes, Google Podcasts, RSS, email Become a patron of TWiV! Show notes at microbe.tv/twiv (Source: virology blog)
Source: virology blog - November 19, 2020 Category: Virology Authors: Vincent Racaniello Tags: This Week in Virology autoantibodies blood clots coronavirus COVID-19 mRNA vaccine pandemic phospholipid SARS-CoV-2 thrombosis tissue tropism viral viruses Source Type: blogs
TWiV 681: Crowley, coats, and cross-reactive antibodies
Daniel Griffin provides a clinical report on COVID-19, Kathleen Crowley explains the role of Environmental Health & Safety departments, update on SARS-CoV-2 transmission in farmed mink, and the presence of pre-existing antibodies to SARS-CoV-2 in unexposed individuals. Click arrow to playDownload TWiV 681 (107 MB .mp3, 179 min)Subscribe (free): iTunes, Google Podcasts, RSS, email Become a patron of TWiV! Show notes at microbe.tv/twiv (Source: virology blog)
Source: virology blog - November 19, 2020 Category: Virology Authors: Vincent Racaniello Tags: This Week in Virology coronavirus COVID in mink COVID-19 cross-reactive antibodies environmental health and safety pandemic Pfizer SARS-CoV-2 vaccine viral viruses Source Type: blogs
Healthcare ’ s Bridge Fire
By KIM BELLARD
We had a bridge fire here in Cincinnati last week. Two semis collided in the overnight hours. The collision ignited a blaze that burned at up to 1500 degrees Fahrenheit and took hours to quell. Fortunately, no one was killed or injured, but the bridge remains closed while investigators determine how much damage was done. It is expected to remain closed for at least another month.
Unfortunately, the bridge in question is the Brent Spence Bridge, which is the focal point for I-71 and I-75 between Ohio and Kentucky. It normally carries over 160,000 vehicles daily, a...
Source: The Health Care Blog - November 17, 2020 Category: Consumer Health News Authors: Christina Liu Tags: COVID-19 Health Policy Kim Bellard Source Type: blogs
Ethics and Society Newsfeed – November 13, 2020
COVID-19 Vaccine ethics: Covid could come back stronger if rich nations monopolise doses“The news that the Pfizer-BioNTech vaccine may prove up to 90 per cent effective at preventing symptoms of Covid has sparked something approaching euphoria across the globe. Stock markets have soared and there is speculation everything could return to “normal” by the spring. But with this […] (Source: blog.bioethics.net)
Source: blog.bioethics.net - November 13, 2020 Category: Medical Ethics Authors: Ethics and Society Tags: Education Ethics Health Care Politics Research Ethics artificial intelligence Biden bioethics compliance coronavirus Covid COVID-19 ethics reform gene editing Harris medical ethics Newsfeed online learning pandemic ra Source Type: blogs
First efficacy results of a COVID-19 vaccine candidate
Results on efficacy of the first of the SARS-CoV-2 candidate vaccines has been announced by Pfizer this week. The company states that the viral spike-encoding mRNA vaccine candidate was found to be more than 90% effective in preventing COVID-19. This announcement is good news, but in itself does not signal the end of the pandemic. […] (Source: virology blog)
Source: virology blog - November 13, 2020 Category: Virology Authors: Vincent Racaniello Tags: Uncategorized Source Type: blogs
Pandemic Ethics: Vaccine distribution ethics: monotheism or polytheism?
Written by Alberto Giubilini, Julian Savulescu, Dominic Wilkinson (Oxford Uehiro Centre for Practical Ethics) (Cross-posted with the Journal of Medical Ethics blog) Pfizer has reported preliminary results that their mRNA COVID vaccine is 90% effective during phase III trials. The hope is to have the first doses available for distribution by the end of the year. […] (Source: blog.bioethics.net)
Source: blog.bioethics.net - November 11, 2020 Category: Medical Ethics Authors: Alberto Giubilini Tags: Health Care Public Health Alberto Giubilini Alberto Giubilini's Posts Coronavirus; Pandemic; Ethics; Public Health Dominic Wilkinson Dominic Wilkinson's Posts Julian Savulescu Julian Savulescu's Posts Pandemic Ethics prioritisation r Source Type: blogs
